Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
China · Delayed Price · Currency is CNY 15.91
-0.20 (-1.24%)
Jun 18, 2026, 3:00 PM CST
SHA:601607 Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, SHA:601607 stock has a consensus rating of "Buy" and an average price target of ¥20.56. The average 1-year stock price forecast is 29.23% higher than the current stock price, while the lowest is ¥12.50 (-21.43%) and the highest is ¥25.88 (+62.66%).
Price Target: ¥20.56 (+29.23%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHA:601607 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 4 | 4 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 9 | 9 | 10 | 10 |
Financial Forecast
Revenue This Year
298.01B
from 283.58B
Increased by 5.09%
Revenue Next Year
317.39B
from 298.01B
Increased by 6.50%
EPS This Year
1.37
from 0.80
Increased by 70.67%
EPS Next Year
1.60
from 1.37
Increased by 17.48%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 302.1B | ||
| Avg | 298.0B | ||
| Low | 293.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.5% | ||
| Avg | 5.1% | ||
| Low | 3.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.37 | ||
| Avg | 1.37 | ||
| Low | 1.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 70.7% | ||
| Avg | 70.7% | ||
| Low | 70.7% |